These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2484701)

  • 21. Interactions between endothelium-derived relaxing factors in the rat hepatic artery: focus on regulation of EDHF.
    Zygmunt PM; Plane F; Paulsson M; Garland CJ; Högestätt ED
    Br J Pharmacol; 1998 Jul; 124(5):992-1000. PubMed ID: 9692786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemin-H2O2-NO2(-) induced protein oxidation and tyrosine nitration are different from those of SIN-1: a study on glutamate dehydrogenase nitrative/oxidative modification.
    Zhang Y; Lu N; Gao Z
    Int J Biochem Cell Biol; 2009 Apr; 41(4):907-15. PubMed ID: 18835362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of oxidizing and reducing agents on ovine pulmonary artery responses to nitric oxide donors, sodium nitroprusside and 3-morpholino-sydnonimine.
    Sardar KK; Sarkar SN; Bawankule DU; Mishra SK; Raviprakash V
    Indian J Exp Biol; 2006 Dec; 44(12):964-70. PubMed ID: 17176668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relaxations to SIN-1, nitric oxide, and sodium nitroprusside in canine arteries and veins.
    Miller VM; Vanhoutte PM
    J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S67-71. PubMed ID: 2484703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell type-dependent release of nitric oxide and/or reactive nitrogenoxide species from intracellular SIN-1: effects on cellular NAD(P)H.
    Swintek AU; Christoph S; Petrat F; de Groot H; Kirsch M
    Biol Chem; 2004 Jul; 385(7):639-48. PubMed ID: 15318813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of linsidomine (SIN 1) after single and multiple intravenous short infusions in patients with renal insufficiency.
    Sennesael J; Verbeelen D; Degré S; Unger P; Stolear JC; Ostrowski J; von Hattingberg HM; Gaertner W
    Int J Clin Pharmacol Ther Toxicol; 1993 Nov; 31(11):533-41. PubMed ID: 8294165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New approach to molsidomine active metabolites coming from the results of 2 models of experimental cardiology.
    Żorniak M; Mitręga KA; Porc M; Krzemiński TF
    Can J Physiol Pharmacol; 2017 Feb; 95(2):111-121. PubMed ID: 27918857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of SIN-1 on electrical responses of the smooth muscle of the canine saphenous vein.
    Komori K; Vanhoutte PM
    J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S62-6. PubMed ID: 2484702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An impurity present in some samples of SIN-1 oxidizes it to nitric oxide in anaerobic solutions.
    Wang Y; Rochelle LG; Kruszyna H; Kruszyna R; Smith RP; Wilcox DE
    Toxicology; 1994 Mar; 88(1-3):165-76. PubMed ID: 8160198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of antioxidants on induction time of luminol luminescence elicited by 3-morpholinosydnonimine (SIN-1).
    Pascual C; Reinhart K
    Luminescence; 1999; 14(2):83-9. PubMed ID: 10398565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SIN-1 stimulates the production of cyclic GMP but not cyclic AMP in porcine aortic endothelial cells.
    Schini VB; Vanhoutte PM
    J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S91-4. PubMed ID: 2484708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of nitric oxide donor SIN-1 on calcium transport in rat cardiac sarcoplasmic reticulum].
    Harmatina OIu; Azarov VI; Moĭbenko OO
    Fiziol Zh (1994); 2001; 47(6):10-4. PubMed ID: 11962084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxidative and adhesive responses of human neutrophils to nitrovasodilators in vitro: the role of protein kinases.
    Klink M; Tchorzewski H; Sulowska Z
    Mediators Inflamm; 2003 Dec; 12(6):345-53. PubMed ID: 14668094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The NO donor SIN-1 improves intestinal-arterial P(CO(2)) gap in experimental endotoxemia: an animal study.
    Siegemund M; Van Bommel J; Sinaasappel M; Schwarte LA; Studer W; Girard T; Vollebregt K; Ince C
    Acta Anaesthesiol Scand; 2007 Jul; 51(6):693-700. PubMed ID: 17567269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical pharmacokinetics of molsidomine.
    Rosenkranz B; Winkelmann BR; Parnham MJ
    Clin Pharmacokinet; 1996 May; 30(5):372-84. PubMed ID: 8743336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamics of Irreversible NO Release from Photoexcited Molsidomine.
    Yoon H; Park S; Lim M
    J Phys Chem Lett; 2023 Jan; 14(2):516-523. PubMed ID: 36626829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxidative/Nitrative Mechanism of Molsidomine Mitotoxicity Assayed by the Cytochrome c Reaction with SIN-1 in Models of Biological Membranes.
    Paes de Barros M; Casares Araujo-Chaves J; Marlise Mendes Brito A; Lourenço Nantes-Cardoso I
    Chem Res Toxicol; 2020 Nov; 33(11):2775-2784. PubMed ID: 32706246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The family of sydnonimines (Corvasal, intracoronary Corvasal 1 mg). Analogies with EDRF (endothelium-derived relaxing factor)].
    Balteaux V
    Presse Med; 1988 May; 17(20):1047-8. PubMed ID: 2969101
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of anti-oxidants on the degradation of SIN-1.
    Quine LA; Carrier MJ; Anggård EE
    Biochem Soc Trans; 1997 Aug; 25(3):417S. PubMed ID: 9388647
    [No Abstract]   [Full Text] [Related]  

  • 40. Kinetics and mechanism of captopril oxidation in aqueous solution under controlled oxygen partial pressure.
    Lee TY; Notari RE
    Pharm Res; 1987 Apr; 4(2):98-103. PubMed ID: 3334413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.